Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Gainers

• Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares surged 64.6% to $2.19 in pre-market trading. Adamis Pharmaceuticals shares declined around 67% on Wednesday after the company reported pricing of $8 million public offering of 5.93 million units at a price of $1.35 per unit.
• T2 Biosystems, Inc. (NASDAQ: TTOO) rose 34.2% to $0.3261 in pre-market trading after gaining 54% on Wednesday. T2 Biosystems recently announced it received an extension to comply with the Nasdaq listing requirements.
• Fangdd Network Group Ltd. (NASDAQ: DUO) gained 23.2% to $0.2267 in pre-market trading after gaining over 13% on Wednesday. FangDD is scheduled to hold an extraordinary general meeting of shareholders on Sept. 15, 2023.
• Upwork Inc. (NASDAQ: UPWK) shares rose 17.1% to $11.67 in pre-market trading after the company posted upbeat second-quarter results and raised full-year guidance.
• EVgo, Inc. (NASDAQ: EVGO) shares gained 15.3% to $4.89 in pre-market trading after the company reported better-than-expected second-quarter results and announced leadership succession plan.
• Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares climbed 14.9% to $0.54 in pre-market trading after jumping over 16% on Wednesday.
• EBET, Inc. (NASDAQ: EBET) rose 14.1% to $0.0670 in pre-market trading after falling 14% on Wednesday. EBET recently initiated review of strategic alternatives.
• Equillium, Inc. (NASDAQ: EQ) gained 13.3% to $0.8501 in pre-market trading after announcing a $7.5 million share repurchase program.
• Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) shares gained 11.6% to $5.87 in pre-market trading after falling over 5% on Wednesday.
• Biophytis S.A. (NASDAQ: BPTS) shares rose 10.2% to $1.51 in pre-market trading after declining more than 20% on Wednesday.

Losers

• Aravive, Inc. (NASDAQ: ARAV) fell 50.8% to $0.6262 in pre-market trading after the company said Phase 3 AXLerate-OC study of batiraxcept in platinum-resistant ovarian cancer did not meet primary endpoint.
• Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares fell 25.7% to $0.1450 in pre-market trading. Helius Medical Technologies is expected to release its second quarter 2023 financial results on Aug. 10, 2023
• Lottery.com Inc. (NASDAQ: LTRY) fell 21.5% to $0.3220 in pre-market trading. Lottery.Com shares jumped 88% on Wednesday after the company announced it regained Nasdaq compliance.
• Neonode Inc. (NASDAQ: NEON) fell 21.4% to $3.09 in pre-market trading. Neonode is scheduled to release the financial results for the three and six months ended June 30, 2023, on Aug. 10, 2023.
• American Superconductor Corporation (NASDAQ: AMSC) fell 21% to $9.05 in pre-market trading after dipping 29% on Wednesday. AMSC is projected to release its first quarter fiscal year 2023 financial results on Aug. 9, 2023.
• DXC Technology Company (NYSE: DXC) fell 19.4% to $21.80 in pre-market trading after the company reported worse-than-expected first-quarter results and issued a below-consensus outlook.
• Vicarious Surgical Inc. (NASDAQ: RBOT) fell 18.2% to $1.35 in pre-market after the company announced pricing of $45 million public offering of 45 million Class A common stock at $1 per share.
• Schrödinger, Inc. (NASDAQ: SDGR) shares fell 17.3% to $41.53 in pre-market trading after posting a wider-than-expected quarterly loss.
• Bruush Oral Care Inc. (NASDAQ: BRSH) shares fell 15.5% to $4.65 in pre-market trading after gaining 10% on Wednesday.
• China Natural Resources, Inc. (NASDAQ: CHNR) fell 14.3% to $2.40 in pre-market trading after jumping 21% on Wednesday. The company recently agreed to sell all outstanding shares of Precise Space-Time Technology to Feishang Group for consideration of approximately $13.2 million.

Now Read This: Apple, Amazon And 3 Stocks To Watch Heading Into Thursday